Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do consumers' attitudes predict prescription purchasing behavior?

Kavita V Nair1

  • 1School of Pharmacy, University of Colorado Health Sciences Center, Denver, USA.

Managed Care Interface
|July 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Descriptive Analysis of Retrospective Observational Real-World Evidence of a Monoclonal Anti-Amyloid Therapy Program in a Wide Catchment Specialty Memory Clinic.

Neurology and therapy·2026
Same author

Virtual vs In-Person Neurologic Ambulatory Care: A Case-Control Study of Subsequent Health Care Utilization.

Neurology·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Using prescription medication utilization trends to evaluate health system resilience and inform future emergency preparedness.

Journal of managed care & specialty pharmacy·2025
Same author

Key Considerations for Assessing Real-World Comparative Effectiveness in the Context of the Drug Price Negotiation Program: A Case Study of Pembrolizumab.

PharmacoEconomics·2025
Same journal

Changes in hospital readmissions for diabetes-related conditions. Differences by payer.

Managed care interface·2008
Same journal

Heart disease and managed care.

Managed care interface·2008
Same journal

A conversation with James K. Min, MD.

Managed care interface·2008
Same journal

Acute coronary syndromes.

Managed care interface·2008
Same journal

Improving outcomes in cardiovascular disease.

Managed care interface·2008
Same journal

The effect for oncology of the national coverage determination for erythropoiesis-stimulating agents.

Managed care interface·2008
See all related articles

Consumer beliefs about medications do not influence prescription choices in three-tier plans. However, increasing copayments appears to improve adherence to health plan formularies.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Behavioral Economics

Background:

  • Three-tier prescription drug plans present consumers with choices between generics, formulary brands, and nonformulary brands.
  • Understanding factors influencing consumer prescription choices is crucial for effective health plan design.

Purpose of the Study:

  • To evaluate the impact of consumer beliefs and perceptions about medications on prescription purchasing behavior.
  • To assess the influence of these beliefs on formulary compliance and medication discontinuation rates within a managed care organization (MCO).

Main Methods:

  • A preliminary evaluation was conducted within a managed care organization (MCO) population.
  • Analysis focused on the relationship between consumer attitudes towards drug coverage, medication perceptions, and purchasing behavior.

Related Experiment Videos

Main Results:

  • Consumer attitudes and perceptions regarding medications did not significantly affect formulary compliance.
  • No demonstrated effect was found on the rates of discontinuation for nonformulary medications.
  • Increasing copayments was associated with greater adherence to health plan formularies.

Conclusions:

  • Consumer beliefs about medications do not appear to be a primary driver of prescription choices in three-tier plans.
  • The findings support the efficacy of three-tier drug formularies in guiding consumer behavior.
  • Financial incentives, such as increased copayments, are effective in promoting adherence to health plan formularies.